Arai, Hidenori

Sarcopenia Definition: The Position Statements of the Sarcopenia Definition and Outcomes Consortium

Bhasin, S., Travison, T. G., Manini, T. M., Patel, S., Pencina, K. M., Fielding, R. A., Magaziner, J. M., Newman, A. B., Kiel, D. P., Cooper, C., et al. (2020) · Journal of the American Geriatrics Society

Nutrition and Health in AgingFrailty in Older Adults

Cited by 723

Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized, Controlled Trial

Ouchi, Y., Sasaki, J., Arai, H., Yokote, K., Harada, K., Katayama, Y., Urabe, T., Uchida, Y., Hayashi, M., Yokota, N., et al. (2019) · Circulation

Lipoproteins and Cardiovascular HealthBlood Pressure and Hypertension Studies

Cited by 231

Anamorelin in Japanese patients with cancer cachexia: an update

Wakabayashi, H., Arai, H., & Inui, A. (2023) · Current Opinion in Supportive & Palliative Care

Nutrition and Health in AgingClinical Nutrition and Gastroenterology

Cited by 17

A Pooled Analysis of Pemafibrate Phase II/III Clinical Trials Indicated Significant Improvement in Glycemic and Liver Function-related Parameters

Yokote, K., Yamashita, S., Arai, H., Araki, E., Suganami, H., & Ishibashi, S. (2018) · Atherosclerosis Supplements

Lipoproteins and Cardiovascular HealthMicroRNA in disease regulation

Cited by 11

Combined effects of social isolation and loneliness on disability incidence in older adults

Shimada, H., Doi, T., Tsutsumimoto, K., Makino, K., Harada, K., Tomida, K., Morikawa, M., & Arai, H. (2025) · Archives of Gerontology and Geriatrics

Aging, Health, and DisabilityHealth disparities and outcomes

Cited by 9

Efficacy and Safety of Pemafibrate Extended-Release Tablet: a Phase 3, Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel-Group Comparison Trial

Arai, H., Yamashita, S., Araki, E., Yokote, K., Tanigawa, R., Saito, A., Yamasaki, S., Suganami, H., & Ishibashi, S. (2024) · Journal of Atherosclerosis and Thrombosis

Peroxisome Proliferator-Activated ReceptorsLipoproteins and Cardiovascular Health

Cited by 8

Effects of Selective PPARα Modulator K-877 on Particle Numbers of Lipoprotein Subclasses in Dyslipidemic Patients: Analysis by GP-HPLC and NMR Lipoprofile 2 and 3

Yamashita, S., Okazaki, M., Okada, T., Masuda, D., Arai, H., Yokote, K., Araki, E., & Ishibashi, S. (2018) · Atherosclerosis Supplements

Lipoproteins and Cardiovascular HealthPeroxisome Proliferator-Activated Receptors

Cited by 2